|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> 乙莫克舍>> 市场分析报告 |
乙莫克舍市场分析报告 |
|
Etomoxir (CAS 124083-20-1) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Etomoxir Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Global Market Report of R-(+)-ETOMOXIR (CAS 124083-20-1) December 2024 Global Market Report of Etomoxir (CAS 82258-36-4) December 2024 CAS 124083-20-1 Etomoxir Chemical Report & Database ... Report & Database definitions: Name: Etomoxir: Etomoxir; (R)-(+)-Etomoxir; (2R)-2-[6-(4-Chlorophenoxy)hexyl]-2-oxiranecarboxylic acid ethyl ... ester Synonyms: (R)-(+)-Etomoxir; (2R)-2-[6-(4-Chlorophenoxy)hexyl]-2-oxiranecarboxylic acid ethyl ... Global Secondary Progressive Multiple Sclerosis Drug Market Report 2020 ... Segmentation Inebilizumab GLX-1112 DC-TAB Etomoxir IB-MS Industry Segmentation Hospital Clinic Channel ... Global Secondary Progressive Multiple Sclerosis Drug Market Growth 2024-2030 ... by type Inebilizumab GLX-1112 DC-TAB Etomoxir IB-MS Others Segmentation by application Hospital Clinic ... Global Secondary Progressive Multiple Sclerosis Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 ... , covers Inebilizumab GLX-1112 DC-TAB Etomoxir IB-MS Others Market segment by Application can ... Secondary Progressive Multiple Sclerosis Drug Market, Global Outlook and Forecast 2022-2028 ... , 2021 (%) Inebilizumab GLX-1112 DC-TAB Etomoxir IB-MS Others Global Secondary Progressive Multiple ... Optic Neuritis - Pipeline Review, H2 2020 Optic Neuritis - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Optic Neuritis - Pipeline Review, H2 2020, provides an overview of the Optic Neuritis (Ophthalmology) pipeline landscape. ... Optic Neuritis - Pipeline Review, H1 2020 Optic Neuritis - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Optic Neuritis - Pipeline Review, H1 2020, provides an overview of the Optic Neuritis (Ophthalmology) pipeline landscape. ... Optic Neuritis (Ophthalmology) - Drugs In Development, 2021 Optic Neuritis (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Optic Neuritis - Drugs In Development, 2021, provides an overview of the Optic Neuritis (Ophthalmology) ... (COVID Version) Global Secondary Progressive Multiple Sclerosis Drug Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use ... by Type Inebilizumab GLX-1112 DC-TAB Etomoxir IB-MS Others Market by Application Hospital Clinic ... 2023-2028 Global and Regional Secondary Progressive Multiple Sclerosis Drug Industry Status and Prospects Professional Market Research Report Standard Version ... By Types: Inebilizumab GLX-1112 DC-TAB Etomoxir IB-MS Others By Applications: Hospital Clinic Others ... Global Secondary Progressive Multiple Sclerosis Drug Market Research Report 2024(Status and Outlook) ... (by Type) Inebilizumab GLX-1112 DC-TAB Etomoxir IB-MS Others Market Segmentation (by Application) Hospital ... |